Clinical Trials on Membranoproliferative Glomerulonephritis
Total 609 results
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and IIINetherlands, Australia, Belgium
-
Mario Negri Institute for Pharmacological ResearchAlexion PharmaceuticalsCompletedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisItaly
-
Celldex TherapeuticsTerminatedC3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis Type IIUnited States
-
Assiut UniversityUnknownMembranoproliferative Glomerulonephritis
-
Mayo ClinicCompletedGlomerulonephritis, MembranoproliferativeUnited States
-
AlexionTerminatedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisUnited States, Australia, Belgium, Italy, Netherlands
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
Columbia UniversityAlexion PharmaceuticalsCompletedDense Deposit Disease | Membranoproliferative GlomerulonephritisUnited States
-
Fernando FervenzaCompleted
-
Mario Negri Institute for Pharmacological ResearchAlexion Pharma Italy s.r.l.Completed
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
Region SkaneRecruitingC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis | Complement AbnormalitySweden
-
Alexion PharmaceuticalsCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited Kingdom, United States
-
University of IowaWithdrawn
-
University of IowaWithdrawn
-
Mario Negri Institute for Pharmacological ResearchRecruitingHealthy | Hemolytic-Uremic Syndrome | Membranoproliferative GlomerulonephritisItaly
-
Apellis Pharmaceuticals, Inc.Active, not recruitingLupus Nephritis | IgA Nephropathy | Membranous Nephropathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited States
-
National Institute of Arthritis and Musculoskeletal...CompletedLupus Nephritis | Glomerulonephritis, MembranoproliferativeUnited States
-
Novartis PharmaceuticalsRecruitingIC-MPGNFrance, Germany, Spain, Switzerland, Japan, United Kingdom, Israel, Brazil, Turkey, Italy, United States, Czechia, Poland
-
Omeros CorporationUnknownLupus Nephritis | IgAN | C3 Glomerulopathy | MNUnited States, Hong Kong
-
Mario Negri Institute for Pharmacological ResearchRecruitingDeveloping a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases (ANTHEM)Healthy | Autosomal Dominant Polycystic Kidney | Atypical Hemolytic Uremic Syndrome | Membranoproliferative GlomerulonephritisItaly
-
University Magna GraeciaCompletedIGA GlomerulonephritisItaly
-
Nagoya UniversityRohto Pharmaceutical Co., Ltd.Completed
-
Centre Hospitalier Universitaire de Saint EtienneCompletedIGA GlomerulonephritisFrance
-
Chinese University of Hong KongRecruitingMembranous NephropathyHong Kong
-
The George InstitutePeking University First HospitalCompletedIgA GlomerulonephritisCanada, China, Australia, Malaysia, Hong Kong, India
-
National Institute of Diabetes and Digestive and...Southwest Pediatric Nephrology Study GroupCompleted
-
National Center for Research Resources (NCRR)Stanford UniversityCompletedIGA Glomerulonephritis
-
Mayo ClinicGenentech, Inc.CompletedFibrillary GlomerulonephritisUnited States
-
National Taiwan University HospitalCompletedPrimary GlomerulonephritisTaiwan
-
BioCryst PharmaceuticalsTerminatedImmunoglobulin A Nephropathy | Membranous Nephropathy | Complement 3 GlomerulopathyFrance, Italy, Spain, United Kingdom
-
National Center for Research Resources (NCRR)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Ohio...CompletedIGA GlomerulonephritisUnited States
-
Assiut UniversityUnknownPSGN - Post-Streptococcal Glomerulonephritis
-
University Medical Center GroningenFresenius Medical Care North AmericaCompletedAnti-glomerular Basement Membrane GlomerulonephritisNetherlands
-
Peking University First HospitalTerminatedKidney Diseases | Glomerulonephritis, IGA | Acute Renal Insufficiency | Rapidly Progressive GlomerulonephritisChina
-
Monia LoriniIstituto Di Ricerche Farmacologiche Mario NegriUnknown
-
Imperial College Healthcare NHS TrustCompletedGlomerulonephritis, MembranousUnited Kingdom
-
Peking UniversityUnknownGlomerulonephritis, IGA
-
Seoul National University HospitalSeoul National University Bundang Hospital; Chung-Ang University Hosptial,... and other collaboratorsRecruitingLupus Nephritis | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Glomerular Disease | Minimal Change Disease | Membranous Nephropathy | Crescentic GlomerulonephritisKorea, Republic of
-
Azienda Socio Sanitaria Territoriale degli Spedali...University of Pisa; Azienda Ospedaliera Universitaria Policlinico; IRCCS Azienda... and other collaboratorsUnknownGlomerulonephritis, MembranousItaly
-
GlaxoSmithKlineCompletedGlomerulonephritis, MembranousUnited Kingdom
-
Centre Hospitalier Universitaire de Saint EtienneCompletedGlomerulonephritis, IGAFrance
-
Air Force Military Medical University, ChinaNot yet recruitingGlomerulonephritis, IGA
-
RWTH Aachen UniversityCompleted
-
Second Xiangya Hospital of Central South UniversityUnknown
-
University Hospital, LimogesUnknownGlomerulonephritis, IGAFrance
-
Novartis PharmaceuticalsTerminatedGlomerulonephritis, MembranousCzechia, India, Taiwan, United Kingdom, Germany, Argentina, China, Netherlands, Spain
-
RemeGen Co., Ltd.Completed